What is Enveric Biosciences Inc Annual Net Profit?

Enveric Biosciences Inc Annual Net Profit rose 44.69% in the last year to $9.57 M. Its sector's average net profit growth for the last fiscal year was -32.44%.

What is Enveric Biosciences Inc Price to Earning Ratio?

Enveric Biosciences Inc Price to Earning Ratio is -0.32, which is negative.

What is Enveric Biosciences Inc Stock Price?

Enveric Biosciences Inc Stock Price rose 39.77% and outperformed its sector by 30.62% in the past year.

What is Enveric Biosciences Inc Quarterly Net profit?

Enveric Biosciences Inc Quarterly Net profit rose 8.19% YoY to $3.15 M. Its sector's average net profit growth YoY for the quarter was -41.97%.

What is Enveric Biosciences Inc Mutual Fund Holding?

Enveric Biosciences Inc Mutual Fund Holding decreased by 1.32% in the last quarter to 6.37.

What is Enveric Biosciences Inc Promoter Share Holding?

Enveric Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 24.89%.

What is Enveric Biosciences Inc Institutional Holding?

Enveric Biosciences Inc Institutional Holding remained the same in the last quarter at 2.41%.

How is the Enveric Biosciences Inc today?

The Enveric Biosciences Inc today is trading in the green, up by 3.36% at 1.23.

How has Enveric Biosciences Inc performed historically?

The Enveric Biosciences Inc is currently trading up 3.36% on an intraday basis in the past week the index fell -3.15%. The index has been up 261.76% in the past quarter and rose 39.77% in the past year. You can view this in the overview section.

Enveric Biosciences Inc XNAS: ENVB

Enveric Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Enveric Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Enveric Biosciences Inc
Rating: 1.82883325
Author: Trendlyne DVM scores

Download real time

1.23 0.04 (3.36%)

74.53% Fall from 52W High

41,432 XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Enveric Biosciences Inc Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	3
PE TTM Negative PE TTM Unavailable in chosen country	-0.3
Price to Book Below industry Median Unavailable in chosen country	1.5
Institutional holding current Qtr % Low in industry Unavailable in chosen country	2.4
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	8.2
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	44.7
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	262.3

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

8.8 / 100

Technically Moderately Bullish

64.3 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Enveric Biosciences Inc Stock Price Analysis

Day Price Range 3.4% 1 Day return Unavailable in chosen country	1.2 (LTP) 1.21.3 LowHigh
Week Price Range -3.2% 1 Week return Unavailable in chosen country	1.2 (LTP) 1.11.3 LowHigh
Month Price Range -29.3% 1 Month return Unavailable in chosen country	1.2 (LTP) 11.8 LowHigh
52 Week Price Range 39.8% 1 Year return Unavailable in chosen country	1.2 (LTP) 0.34.8 LowHigh

View full Share Price History

Enveric Biosciences Inc Live Price Chart

Switch to TradingView

Fetching data ...

Enveric Biosciences Inc Stock Analysis

Enveric Biosciences Inc stock analysis with key metrics, changes, and trends.

Enveric Biosciences Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$9.57 M	44.69%	positive	Annual Net Profit rose 44.69% in the last year to $9.57 M. Its sector's average net profit growth for the last fiscal year was -32.44%.
Price to Earning Ratio	-0.32	-	negative	Price to Earning Ratio is -0.32, which is negative.
Stock Price	$1.23	39.77%	positive	Stock Price rose 39.77% and outperformed its sector by 30.62% in the past year.
Quarterly Net profit	$3.15 M	8.19%	positive	Quarterly Net profit rose 8.19% YoY to $3.15 M. Its sector's average net profit growth YoY for the quarter was -41.97%.
Mutual Fund Holding	6.37 %	-1.32%	negative	Mutual Fund Holding decreased by 1.32% in the last quarter to 6.37.
Promoter Share Holding	24.89 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 24.89%.
Institutional Holding	2.41 %	0%	neutral	Institutional Holding remained the same in the last quarter at 2.41%.

VIEW LESS

Loading data..

Enveric Biosciences Inc - Company Profile

What does Enveric Biosciences Inc do?

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

2024

Gross Remuneration

Year

Enveric Biosciences Inc Live Share Price Today, Share Analysis and Chart

74.53% Fall from 52W High

Enveric Biosciences Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Enveric Biosciences Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Enveric Biosciences Inc Live Price Chart

Enveric Biosciences Inc Stock Analysis

Enveric Biosciences Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 44.69% in the last year to $9.57 M. Its sector's average net profit growth for the last fiscal year was -32.44%.

Price to Earning Ratio is -0.32, which is negative.

Stock Price rose 39.77% and outperformed its sector by 30.62% in the past year.

Quarterly Net profit rose 8.19% YoY to $3.15 M. Its sector's average net profit growth YoY for the quarter was -41.97%.

Mutual Fund Holding decreased by 1.32% in the last quarter to 6.37.

Promoter Share Holding stayed the same in the most recent quarter at 24.89%.

Institutional Holding remained the same in the last quarter at 2.41%.

Enveric Biosciences Inc - Company Profile

What does Enveric Biosciences Inc do?

Enveric Biosciences Inc Management structure

Dr. Joseph Tucker, PhD

Chief Executive Officer and Director

Mr. Kevin M. Coveney

Chief Financial Officer and Principal Accounting Officer

Dr. Peter Facchini, PhD

Chief Innovation Officer

Enveric Biosciences Inc Board of directors

Mr. Michael D. Webb

Chairman of the Board

Mr. Frank Pasqualone

Independent Director

Mr. George Kegler

Independent Director

Dr. Marcus Schabacker, M.D.,PhD

Independent Director

Ms. Sheila DeWitt

Director

Dr. Joseph Tucker, PhD

Chief Executive Officer and Director

Enveric Biosciences Inc FAQ

How is Enveric Biosciences Inc today?

Enveric Biosciences Inc today is trading in the green, and is up by 3.36% at 1.23.

How has Enveric Biosciences Inc performed historically?

Enveric Biosciences Inc is currently trading up 3.36% on an intraday basis. In the past week the stock fell -3.15%. stock has been up 261.76% in the past quarter and rose 39.77% in the past year. You can view this in the overview section.